NEW YORK (GenomeWeb) – Agilent Technologies and BioTek Instruments have partnered to develop an integrated product for cellular metabolic analysis and imaging.

Specifically, the companies will integrate Agilent's Seahorse XFe96/XFe24 Analyzers with BioTek's Cytation 1 Cell Imaging Multi-Mode Reader. The combined product will enable a standardized approach to compare XF data sets, improve assay workflow, embed images into WAVE software, and apply normalization values to Seahorse XF measurements.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.